Evidence map›Paper›PMID 29843526›Full record

Observational studyThe American journal of hospice & palliative care2018

The Role of Palliative Medicine in Assessing Hereditary Cancer Risk.

Mohammed S Abusamaan, John Martin Quillin, Oluwafemi Owodunni, Oluwabunmi Emidio, In Guk Kang, Brandon Yu, Brittany Ma, Lauryn Bailey, Rab Razzak, Thomas J Smith and 1 more

Open access · greenAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in The American journal of hospice & palliative care, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Mohammed S Abusamaan1 Johns Hopkins University School of Medicine, Baltimore MD, USA.ORCID http://orcid.org/0000-0001-9307-1315
John Martin Quillin2 Virginia Commonwealth University, Richmond, VA, USA.
Oluwafemi Owodunni1 Johns Hopkins University School of Medicine, Baltimore MD, USA.
Oluwabunmi Emidio1 Johns Hopkins University School of Medicine, Baltimore MD, USA.
In Guk Kang3 Johns Hopkins University, Baltimore MD, USA.
Brandon Yu3 Johns Hopkins University, Baltimore MD, USA.
Brittany Ma3 Johns Hopkins University, Baltimore MD, USA.
Lauryn Bailey3 Johns Hopkins University, Baltimore MD, USA.
Rab Razzak1 Johns Hopkins University School of Medicine, Baltimore MD, USA.
Thomas J Smith1 Johns Hopkins University School of Medicine, Baltimore MD, USA.
Joann N Bodurtha1 Johns Hopkins University School of Medicine, Baltimore MD, USA.
Johns Hopkins University · USVirginia Commonwealth University · US

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
NCI NIH HHS P30 CA006973
6 · The paper itself

Abstract

background: Hereditary cancer assessment and communication about family history risks can be critical for surviving relatives. Palliative care (PC) is often the last set of providers before death.

methods: We replicated a prior study of the prevalence of hereditary cancer risk among patients with cancer receiving PC consultations, assessed the history in the electronic medical record (EMR), and explored patients' attitudes toward discussions about family history. This study was conducted at an academic urban hospital between June 2016 and March 2017.

results: The average age of the 75 adult patients with cancer was 60 years, 49 (55%) male and 49 (65%) white. A total of 19 (25%) patients had no clear documentation of family history in the EMR, sometimes because no family history was included in the admission template or an automatically imported template lacked content. In all, 24 (32%) patients had high-risk pedigrees that merited referral to genetic services. And, 48 (64%) patients thought that PC was an appropriate venue to discuss the implications of family history. The mean comfort level in addressing these questions was high.

conclusions: At an academic center, 25% of patients had no family history documented in the EMR. And, 32% of pedigrees warranted referral to genetic services, which was rarely documented. There is substantial room for quality improvement for oncologists and PC specialists-often the last set of providers-to address family cancer risk before death and to increase use and ease of documenting family history in the EMR. Addressing cancer family history could enhance prevention, especially among high-risk families.

Indexed as

Academic Medical CentersAgedAttitudeElectronic Health RecordsFemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedNeoplasmsPalliative CareProspective StudiesSocioeconomic Factorscancerelectronic health recordfamily historygenetic referralgenetic riskpalliative care

Identifiers

PMID29843526
PMCPMC6385866
OpenAlexW2805365451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.